Meropenem Bradex

Meropenem, the active ingredient in Meropenem Bradex, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections in hospitalized patients, including those caused by multi‑drug‑resistant organisms.

GNH USA supplies Meropenem Bradex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem Bradex is a broad‑spectrum carbapenem used to treat serious infections caused by susceptible bacteria. - Complicated intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens. - Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: provides rapid bacterial clearance. - Complicated urinary tract infections: eliminates resistant Gram‑negative organisms. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections. - Sepsis and febrile neutropenia: offers coverage for polymicrobial bloodstream infections.

Adverse reactions to Meropenem Bradex can vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional episodes after infusion. - Rash: transient erythematous skin eruptions. - Headache: mild discomfort during treatment. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment. - Anaphylaxis: acute hypersensitivity reaction requiring immediate care. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Stevens‑Johnson syndrome: rare mucocutaneous blistering disorder.

Careful assessment and monitoring are essential when using Meropenem Bradex. - Renal function assessment: adjust dose in patients with impaired clearance. - Seizure risk monitoring: observe patients with pre‑existing CNS disorders. - Allergy review: avoid use in individuals with known carbapenem hypersensitivity. - Neonatal use caution: limit to confirmed infections due to limited data. - Concomitant nephrotoxic drugs: monitor renal parameters closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem Bradex may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: may lower serum levels, risking seizure breakthrough. - Oral contraceptives: reduced hormonal effectiveness, consider alternative contraception. - Aminoglycosides: additive nephrotoxicity, avoid simultaneous high‑dose use.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Anticoagulants (e.g., warfarin): watch INR for potential changes. - Other broad‑spectrum antibiotics: assess for overlapping toxicity. - Antiepileptic drugs (e.g., phenytoin): monitor seizure control.